340B is a Hidden Tax Expenditure
That is the argument made by Ike Brannon and Anthony Lo Sasso in a recent…
340B is a Hidden Tax Expenditure
That is the argument made by Ike Brannon and Anthony Lo Sasso in a recent Health Affairs Forefront article. 340B allows hospitals serving low income communities to purchase pharmaceuticals at discounted rates, but then receive full price reimbursement from payers (e.g., commercial insurers, Medicare). It is not clear that the 340B program even benefits low-income…
Startup Helping Providers Manage Denied Claims Raises $16M
Amperos Health’s Series A round was led by Bessemer Venture Partners, with participation from Uncork Capital and Neo. The post Startup Helping Providers Manage Denied Claims Raises $16M appeared first on MedCity News.
VC Firm Kurma Partners Closes €215M Fund in Pursuit of ‘Disruptive Therapeutic Solutions’
Kurma Partners’ new fund is the venture capital firm’s fourth and largest. Previous Kurma investments have led to exits that include the acquisitions of Corlieve Therapeutics, Emergence Therapeutics, and Amolyt Pharma. The post VC Firm Kurma Partners Closes €215M Fund in Pursuit of ‘Disruptive Therapeutic Solutions’ appeared first on MedCity News.
Beyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy
Telehealth clinic Hone Health partnered with imaging company BodySpec to give its patients access to DEXA body composition scans. The partnership seeks to help providers and patients on GLP-1s distinguish fat loss from muscle loss and better evaluate how these drugs are affecting the body. The post Beyond the Scale: How Imaging Can Help Determine…
The Cancer Crisis We Can See Coming And Have the Tools to Change
Colon cancer has long been considered a disease that comes with old age. However, the trend line of disease has been moving in the wrong direction for years, in a population we long assumed wasn’t at risk. And while researchers continue to investigate the why, there’s a parallel conversation we aren’t having nearly enough. One…
Precision Delivered: How Radiopharmaceuticals Are Reshaping Cancer Care
As radiopharmaceuticals continue to evolve, the convergence of scientific innovation, operational practicality, and clinical expertise is opening new possibilities in oncology. The post Precision Delivered: How Radiopharmaceuticals Are Reshaping Cancer Care appeared first on MedCity News.
The Brand-Driven Flywheel: Igniting Growth Through a Simple Patient Experience
Direct-to-patient (DTP) models create a continuous loop of value, connecting seamless patient and provider experience with the strategic power of branding and data. The post The Brand-Driven Flywheel: Igniting Growth Through a Simple Patient Experience appeared first on MedCity News.
Top Silicon Valley VCs Are Backing a New Health Tech Residency Program
The AI Health Fund launched Treehub, a new residency program designed to back and build healthcare AI startups at the earliest stages, often before companies are even formed. It is supported by prominent figures in the Silicon Valley venture capital world, including Tim Draper and Anne Wojcicki. The post Top Silicon Valley VCs Are Backing…
Regeneron Gets Landmark FDA Approval for First Gene Therapy for Hearing Loss
Regeneron Pharmaceuticals’ Otarmeni is now approved for treating hearing loss from an ultra-rare genetic mutation found in an estimated 50 newborns per year. While Regeneron will offer this gene therapy for free, the approval came with a rare pediatric disease priority review voucher that the company can sell for hundreds of millions of dollars. The…
